SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-476783
Filing Date
2016-02-25
Accepted
2016-02-25 06:10:35
Documents
7
Period of Report
2016-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d129782d8k.htm 8-K 22576
2 EX-1.1 d129782dex11.htm EX-1.1 121882
3 EX-4.2 d129782dex42.htm EX-4.2 156063
4 EX-5.1 d129782dex51.htm EX-5.1 16260
5 EX-12.1 d129782dex121.htm EX-12.1 19571
6 GRAPHIC g129782g0224033151649.jpg GRAPHIC 2263
7 GRAPHIC g129782g0224033151743.jpg GRAPHIC 1727
  Complete submission text file 0001193125-16-476783.txt   343399
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 161453746
SIC: 2836 Biological Products, (No Diagnostic Substances)